A 4-year-old spayed female Golden Retriever is rushed to ...

☠️ This is a critical situation, and immediate, aggressive intervention is required. Acute collapse and seizures with a blood glucose of 35 mg/dL indicate severe xylitol toxicosis leading to profound hypoglycemia and secondary neurological signs. While we don't know the exact dose ingested, the clinical presentation dictates an emergency protocol.

Here's the immediate action plan:

Emergency Management Protocol for Severe Xylitol Toxicosis

Immediate Stabilization & IV Access:

* Secure Airway: Ensure a patent airway. If the dog is in active status epilepticus and airway patency is compromised, consider intubation.
* Establish IV Catheter: Place a large-bore intravenous catheter immediately. This is essential for administering emergency medications and fluids.

Manage Seizures:

* Administer an anticonvulsant to stop the active seizure.
* Diazepam: 0.5-1 mg/kg IV. Administer slowly to effect. This may need to be repeated if seizures recur.
* If seizures are refractory, consider other anticonvulsants such as levetiracetam or propofol CRI, but prioritize stopping the immediate seizure activity.

Correct Hypoglycemia:

* This is paramount. Blood glucose of 35 mg/dL is life-threatening and directly contributing to the neurological signs.
* Dextrose Bolus: Administer a bolus of 50% dextrose at 0.5-1 mL/kg IV. Crucially, dilute the 50% dextrose at least 1:1 with 0.9% NaCl or LRS before administration to prevent phlebitis and hyperosmolarity.
* Dextrose Constant Rate Infusion (CRI): Immediately follow the bolus with a 2.5-5% dextrose CRI. This is typically achieved by adding 50% dextrose to your maintenance crystalloid fluids (e.g., adding 50 mL of 50% dextrose to 1L of LRS creates a 2.5% dextrose solution).
* Monitor Blood Glucose (BG) Freqently: Check BG every 15-30 minutes initially, then every 1-2 hours once stable, for at least 12-24 hours. Adjust the dextrose CRI rate to maintain normoglycemia (80-120 mg/dL). Rapid fluctuations should be avoided.

Decontamination (Contraindicated in this state):

* Emesis: Absolutely contraindicated in a seizing or obtunded patient due to the high risk of aspiration.
* Activated Charcoal: Xylitol is poorly adsorbed by activated charcoal, and in a patient with active seizures, it poses an aspiration risk. Therefore, activated charcoal is generally not recommended in this scenario.

Supportive Care & Monitoring:

* IV Fluids: Continue intravenous crystalloid fluids (e.g., LRS, 0.9% NaCl) at maintenance rates to support hydration and perfusion.
* Thermal Support: Monitor body temperature. Hypothermia can occur with collapse and seizures. Provide warming measures if necessary.
* Electrolyte Monitoring: Xylitol-induced insulin release can lead to hypokalemia. Monitor electrolytes and supplement as needed.
* Neurological Monitoring: Closely monitor for recurrence of seizures, mentation changes, and other neurological signs.
* Liver Monitoring (Delayed Concern): Xylitol can cause acute hepatic necrosis, particularly at doses >0.5 g/kg. Even if the initial presentation is hypoglycemia, liver damage can develop 12-72 hours post-ingestion.
* Collect baseline liver enzymes (ALT, ALP, bilirubin).
* Recheck liver enzymes at 24, 48, and 72 hours post-ingestion.
* Consider initiating hepatoprotectants such as N-acetylcysteine (140 mg/kg loading dose PO or IV, then 70 mg/kg q4-6h for 7 doses, as per formulary) and S-Adenosylmethionine (SAMe) empirically, especially if a significant ingestion is suspected or liver enzymes begin to rise.

Prognosis

* Hypoglycemia: Prognosis is generally good if the hypoglycemia is identified and aggressively treated before irreversible neurological damage occurs.
* Hepatotoxicity: If liver failure develops, the prognosis is guarded to poor. Early and aggressive monitoring of liver enzymes is critical.

This dog requires immediate and intensive veterinary care in an emergency setting. The priority is to stop the seizures and correct the profound hypoglycemia, then to monitor for and prevent secondary complications like liver failure.